​

 

We have dedicated our research to three distinct areas: Aptamers, Vaccines, and Small Molecule Drugs. Our aim is directed towards the development of new therapies to fight used in fighting cancer and autoimmune disease. The goal of developing immunotherapy drugs is to activate the immune system to create autoimmune-like conditions that can where as they assist the body in lysing cancer cells and tumors of any stage and/or to halt the re-emergence of new tumor activity.

​